Gustafsson B, Persson C G
Pharmacological Laboratory, AB Draco, Lund, Sweden.
Thorax. 1989 Jan;44(1):24-7. doi: 10.1136/thx.44.1.24.
An investigation was carried out to determine whether the sensitivity of rat tracheal smooth muscle to contractile and relaxant drugs was affected by three weeks' treatment with subcutaneous budesonide before death. Budesonide treatment was associated with a lower thymus weight and a smaller gain in body weight than in control animals. There was, however, no difference in the carbachol concentration-response curves or maximum responses to carbachol of tracheal smooth muscle from control and budesonide treated rats. Isometric and isotonic recordings agreed in these respects. Glucocorticoid treatment did not increase the sensitivity of tracheal smooth muscle to the relaxant drugs terbutaline and enprofylline; if anything there was a tendency for terbutaline and enprofylline to be less potent after budesonide treatment. The data suggest that in vivo effects of glucocorticoids on airway responsiveness to bronchodilating and bronchoconstricting drugs are unlikely to be due to a direct effect on bronchial smooth muscle.
开展了一项研究,以确定在处死前皮下注射布地奈德三周的处理是否会影响大鼠气管平滑肌对收缩和舒张药物的敏感性。与对照动物相比,布地奈德处理组的胸腺重量较低,体重增加较少。然而,对照大鼠和布地奈德处理大鼠的气管平滑肌对卡巴胆碱的浓度-反应曲线或对卡巴胆碱的最大反应并无差异。等长和等张记录在这些方面是一致的。糖皮质激素处理并未增加气管平滑肌对舒张药物特布他林和恩丙茶碱的敏感性;如果有任何影响的话,布地奈德处理后特布他林和恩丙茶碱的效力有降低的趋势。这些数据表明,糖皮质激素对气道对支气管扩张和支气管收缩药物反应性的体内作用不太可能是由于对支气管平滑肌的直接作用。